Tenaya Therapeutics, Inc. (TNYA) Tops Q2 EPS by 5c
Tweet
Share
E-mailGet Alerts TNYA Hot Sheet
Join SI Premium – FREE
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) reported Q2 EPS of ($0.45), $0.05 better than the analyst estimate of ($0.50).
For earnings history and earnings-related data on Tenaya Therapeutics, Inc. (TNYA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
